Comparison of Clinical Efficacy of Intravitreal Ranibizumab with and without Triamcinolone Acetonide in Macular Edema Secondary to Central Retinal Vein Occlusion

医学 丙酮 眼科 黄斑水肿 血管抑制剂 视网膜中央静脉阻塞 曲安奈德 视力 视网膜分支静脉阻塞 闭塞 视网膜 外科 贝伐单抗 化疗
作者
Chuanfeng Fan,Yu Wang,Qiang Ji,Bojun Zhao,Juan Xie
出处
期刊:Current Eye Research [Taylor & Francis]
卷期号:39 (9): 938-943 被引量:12
标识
DOI:10.3109/02713683.2014.885533
摘要

Purpose: To compare visual outcomes and spectral-domain optical coherence tomography results following treatment with intravitreal ranibizumab (IVR) or IVR combined with intravitreal triamcinolone acetonide (IVTA) for macular edema (ME) secondary to central retinal vein occlusion (CRVO).Methods: This prospective, case-controlled study examined 57 eyes (57 patients) with ME secondary to CRVO, which were treated with IVR (0.5 mg, n = 30 eyes) or IVR (0.5 mg) and IVTA (1 mg, n = 27 eyes) as the initial therapy. Further intravitreal treatment was administered as necessary.Results: All 57 patients completed at least 6 months of follow-up. At baseline, mean ( ± standard error) best-corrected visual acuity (BCVA) was 45.8 ± 23.2 letters in the IVR group and 47.3 ± 19.3 letters in the IVR + IVTA group (p = 0.790). Significant improvement in BCVA over baseline was observed in both groups at all six study visits (IVR group: p = 0.0003, 0.0001, 0.0018, 0.0145, 0.0107, 0.005; IVR + IVTA group: p = 0.0001, 0.0001, 0.0004, 0.0068, 0.0007, 0.0002), with no significant BCVA differences between groups. Significant reduction in mean central subfield thickness, compared with baseline, was also observed in both groups at all six study visits (IVR group, p = 0.0001; IVR + IVTA group, p = 0.0001), with no significant difference between groups in the magnitude of macular thickness reduction. The mean number of injections was significantly higher (p = 0.0001) in the IVR group (4.23 ± 0.56) than in the IVR + IVTA group (3.42 ± 0.41).Conclusions: Treating ME secondary to CRVO with IVR or IVR + IVTA had similar effects on central macular thickness and BCVA in patients with ME secondary to CRVO over a 6-month follow-up period. The mean number of intravitreal injections was higher in the IVR group than in the IVR + IVTA group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
米九完成签到,获得积分10
2秒前
zhao完成签到,获得积分10
5秒前
普鲁卡因发布了新的文献求助10
5秒前
zj完成签到,获得积分10
11秒前
蓝橙完成签到,获得积分10
12秒前
16秒前
GD88完成签到,获得积分10
17秒前
糟糕的梨愁完成签到,获得积分10
18秒前
莫西莫西完成签到 ,获得积分10
19秒前
小趴蔡完成签到 ,获得积分10
21秒前
唐唐发布了新的文献求助10
21秒前
飘逸剑身完成签到,获得积分10
24秒前
airtermis完成签到 ,获得积分10
24秒前
gfasdjsjdsjd完成签到,获得积分10
25秒前
25秒前
杨宁完成签到 ,获得积分10
25秒前
MchemG应助transition采纳,获得20
26秒前
科研通AI2S应助科研通管家采纳,获得10
27秒前
lxy发布了新的文献求助10
29秒前
gfasdjsjdsjd发布了新的文献求助10
30秒前
JCao727完成签到,获得积分10
30秒前
30秒前
31秒前
OAHCIL完成签到 ,获得积分10
32秒前
lixueao发布了新的文献求助10
33秒前
无辜的行云完成签到 ,获得积分0
36秒前
FIN应助gfasdjsjdsjd采纳,获得20
38秒前
今后应助gfasdjsjdsjd采纳,获得10
38秒前
排骨炖豆角完成签到 ,获得积分10
40秒前
一叶知秋应助大橙子采纳,获得10
42秒前
kk完成签到,获得积分10
45秒前
敏感春天完成签到,获得积分10
45秒前
凶狠的期待完成签到,获得积分10
47秒前
自然函发布了新的文献求助30
47秒前
JF123_完成签到 ,获得积分10
48秒前
量子星尘发布了新的文献求助10
48秒前
50秒前
杨召发布了新的文献求助10
51秒前
didi完成签到,获得积分10
51秒前
keyby发布了新的文献求助10
53秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022